James Hassard, Chief Commercial Officer at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 15,625 shares at $75.00 ($1.2M) on 2021-01-07, disclosed to the SEC on 2021-01-08.
Open-market sale of $1.2M ARWR by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ARWR | SELL | 2021-06-24 | $647K | — | Filing → |